Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
3.250
-0.060 (-1.81%)
At close: May 14, 2025, 4:00 PM
3.210
-0.040 (-1.23%)
After-hours: May 14, 2025, 6:14 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $226.36 million as of May 14, 2025. Its market cap has decreased by -57.87% in one year.
Market Cap
226.36M
Enterprise Value
578.68M
1-Year Change
-57.87%
Ranking
Category
Stock Price
$3.25
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has decreased from $527.13M to $226.36M, a decrease of -57.06%. That is a compound annual growth rate of -14.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 642.38B |
Johnson & Johnson | 352.15B |
AbbVie | 313.43B |
Novo Nordisk | 288.64B |
UnitedHealth Group | 279.41B |
Abbott Laboratories | 223.67B |
Novartis AG | 208.47B |
AstraZeneca | 206.71B |